These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

108 related articles for article (PubMed ID: 35016041)

  • 21. Interpretation of continuous glucose monitoring data: glycemic variability and quality of glycemic control.
    Rodbard D
    Diabetes Technol Ther; 2009 Jun; 11 Suppl 1():S55-67. PubMed ID: 19469679
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Improved quality of glycemic control and reduced glycemic variability with use of continuous glucose monitoring.
    Rodbard D; Bailey T; Jovanovic L; Zisser H; Kaplan R; Garg SK
    Diabetes Technol Ther; 2009 Nov; 11(11):717-23. PubMed ID: 19905888
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Assessment of glucose variability in subjects with prediabetes.
    Chakarova N; Dimova R; Grozeva G; Tankova T
    Diabetes Res Clin Pract; 2019 May; 151():56-64. PubMed ID: 30935927
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Glucose Variability: Comparison of Different Indices During Continuous Glucose Monitoring in Diabetic Patients.
    Le Floch JP; Kessler L
    J Diabetes Sci Technol; 2016 Jul; 10(4):885-91. PubMed ID: 26880391
    [TBL] [Abstract][Full Text] [Related]  

  • 25. TSH oscillations in young patients with type 1 diabetes may be due to glycemic variability.
    Bellastella G; Maiorino MI; Scappaticcio L; Casciano O; Petrizzo M; Caputo M; Paglionico VA; Giugliano D; Esposito K
    J Endocrinol Invest; 2018 Apr; 41(4):389-393. PubMed ID: 28856591
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Measures of Glycemic Variability in Type 1 Diabetes and the Effect of Real-Time Continuous Glucose Monitoring.
    El-Laboudi AH; Godsland IF; Johnston DG; Oliver NS
    Diabetes Technol Ther; 2016 Dec; 18(12):806-812. PubMed ID: 27996321
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Adiponectin and insulin resistance in childhood obesity.
    Panagopoulou P; Galli-Tsinopoulou A; Fleva A; Pavlitou-Tsiontsi E; Vavatsi-Christaki N; Nousia-Arvanitakis S
    J Pediatr Gastroenterol Nutr; 2008 Sep; 47(3):356-62. PubMed ID: 18728534
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Association of Waist Circumference and Body Fat Weight with Insulin Resistance in Male Subjects with Normal Body Mass Index and Normal Glucose Tolerance.
    Sasaki R; Yano Y; Yasuma T; Onishi Y; Suzuki T; Maruyama-Furuta N; Gabazza EC; Sumida Y; Takei Y
    Intern Med; 2016; 55(11):1425-32. PubMed ID: 27250047
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Effects of laparoscopic sleeve gastrectomy on insulin secretion patterns in morbidly obese patients].
    Qian C; Zhu C; Gao J; Bu L; Zhou D; Li N; Qu S
    Zhonghua Wei Chang Wai Ke Za Zhi; 2018 Jan; 21(1):61-67. PubMed ID: 29354901
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Relationship between glucose variability evaluated by continuous glucose monitoring and clinical factors, including glucagon-stimulated insulin secretion in patients with type 2 diabetes.
    Ohara M; Hiromura M; Nagaike H; Kohata Y; Fujikawa T; Goto S; Sato N; Kushima H; Terasaki M; Yamamoto T; Mori Y; Hayashi T; Fukui T; Yamagishi SI; Hirano T
    Diabetes Res Clin Pract; 2019 Dec; 158():107904. PubMed ID: 31672500
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Insulin secretion and incretin hormones after oral glucose in non-obese subjects with impaired glucose tolerance.
    Rask E; Olsson T; Söderberg S; Holst Jj Jj; Tura A; Pacini G; Ahrén B
    Metabolism; 2004 May; 53(5):624-31. PubMed ID: 15131768
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Continuous glucose monitoring reveals similar glycemic variability in individuals with obesity despite increased HOMA-IR.
    Cooper DJ; Zarabi S; Farrand B; Becker A; Roslin M
    Front Nutr; 2022; 9():1070187. PubMed ID: 36570168
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Regional fat mass by DXA: high leg fat mass attenuates the relative risk of insulin resistance and dyslipidaemia in obese but not in overweight postmenopausal women.
    Aasen G; Fagertun H; Halse J
    Scand J Clin Lab Invest; 2008; 68(3):204-11. PubMed ID: 18446527
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Effect of android to gynoid fat ratio on insulin resistance in obese youth.
    Aucouturier J; Meyer M; Thivel D; Taillardat M; Duché P
    Arch Pediatr Adolesc Med; 2009 Sep; 163(9):826-31. PubMed ID: 19736336
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Glucose Fluctuations during Gestation: An Additional Tool for Monitoring Pregnancy Complicated by Diabetes.
    Dalfrà MG; Chilelli NC; Di Cianni G; Mello G; Lencioni C; Biagioni S; Scalese M; Sartore G; Lapolla A
    Int J Endocrinol; 2013; 2013():279021. PubMed ID: 24319455
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Pancreatic fat and β-cell function in overweight/obese children with nonalcoholic fatty liver disease.
    Pacifico L; Di Martino M; Anania C; Andreoli GM; Bezzi M; Catalano C; Chiesa C
    World J Gastroenterol; 2015 Apr; 21(15):4688-95. PubMed ID: 25914480
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Risk of future diabetes is as high with abnormal intermediate post-glucose response as with impaired glucose tolerance.
    Viswanathan V; Clementina M; Nair BM; Satyavani K
    J Assoc Physicians India; 2007 Dec; 55():833-7. PubMed ID: 18405128
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The application of simple metrics in the assessment of glycaemic variability.
    Monnier L; Colette C; Owens DR
    Diabetes Metab; 2018 Sep; 44(4):313-319. PubMed ID: 29602622
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Association of fat to lean mass ratio with metabolic dysfunction in women with polycystic ovary syndrome.
    Ezeh U; Pall M; Mathur R; Azziz R
    Hum Reprod; 2014 Jul; 29(7):1508-17. PubMed ID: 24813197
    [TBL] [Abstract][Full Text] [Related]  

  • 40. beta-Cell function in subjects spanning the range from normal glucose tolerance to overt diabetes: a new analysis.
    Ferrannini E; Gastaldelli A; Miyazaki Y; Matsuda M; Mari A; DeFronzo RA
    J Clin Endocrinol Metab; 2005 Jan; 90(1):493-500. PubMed ID: 15483086
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.